参考文献 References
[1] Shao B, Yang W, Cao Q. Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030. *Front Public Health*. 2022. 10:1032679.
[2] Ocansey, D.K.W., et al., Exosome-mediated effects and applications in inflammatory bowel disease. Biol Rev Camb Philos Soc, 2020. 95(5): p. 1287-1307.
[3] Maoka, T., Carotenoids as natural functional pigments. J Nat Med, 2020. 74(1): p. 1-16.
[4] Wang, L., et al., Biotechnology advances in β-carotene production by microorganisms. Trends in Food Science & Technology, 2021. 111: p. 322-332.
[5] Jing, Y., et al., Advances in the synthesis of three typical tetraterpenoids including β-carotene, lycopene and astaxanthin. Biotechnology Advances, 2022. 61: p. 108033.
[6] Li, S., et al., An improved method for the separation of carotenoids and carotenoid isomers by liquid chromatography-mass spectrometry. J Sep Sci, 2021. 44(2): p. 539-548.
[7] Terao, J., Revisiting carotenoids as dietary antioxidants for human health and disease prevention. Food Funct, 2023. 14(17): p. 7799-7824.
[8] Jing, Y., et al., Recent Advances on Biological Synthesis of Lycopene by Using Industrial Yeast. Industrial & Engineering Chemistry Research, 2021. 60(9): p. 3485-3494.
[9] Liu, C., et al., Carotenoids from fungi and microalgae: A review on their recent production, extraction, and developments. Bioresource Technology, 2021. 337: p. 125398.
[10] Hernández-Almanza, A., et al., Lycopene: Progress in microbial production. Trends in Food Science & Technology, 2016. 56: p. 142-148.
[11] Borel, P., et al., Lycopene bioavailability is associated with a combination of genetic variants. Free Radical Biology and Medicine, 2015. 83: p. 238-244.
[12] Muhammad, A., et al., Production of plant natural products through engineered Yarrowia lipolytica. Biotechnology Advances, 2020. 43: p. 107555.
[13] Mitra, S., et al., Potential health benefits of carotenoid lutein: An updated review. Food Chem Toxicol, 2021. 154: p. 112328.
[14] Kong, K.-W., et al. Revealing the Power of the Natural Red Pigment Lycopene. Molecules, 2010. 15, 959-987 DOI: 10.3390/molecules15020959.
[15] Müller, L., et al., Lycopene and Its Antioxidant Role in the Prevention of Cardiovascular Diseases-A Critical Review. Crit Rev Food Sci Nutr, 2016. 56(11): p. 1868-79.
[16] Di Mascio, P., S. Kaiser, and H. Sies, Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys, 1989. 274(2): p. 532-8.
[17] Laurindo, L.F., et al., Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites, 2023. 13(1).
[18] Huang, M.T., G. Ghai, and C.T. Ho, Inflammatory Process and Molecular Targets for Antiinflammatory Nutraceuticals. Compr Rev Food Sci Food Saf, 2004. 3(4): p. 127-139.
[19] Sies, H. and W. Stahl, Lycopene: antioxidant and biological effects and its bioavailability in the human. Proc Soc Exp Biol Med, 1998. 218(2): p. 121-4.
[20] Eleutherio, E.C.A., et al., SOD1, more than just an antioxidant. Archives of Biochemistry and Biophysics, 2021. 697: p. 108701.
[21] Yang, H., et al., The protective role of procyanidins and lycopene against mercuric chloride renal damage in rats. Biomedical and Environmental Sciences, 2011. 24(5): p. 550-559.
[22] Kuhad, A., R. Sethi, and K. Chopra, Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sciences, 2008. 83(3): p. 128-134.
[23] Liu, X., et al. Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. in Asia Pacific Journal of Clinical Nutrition. 2007.
[24] Veeramachaneni, S., et al., High Dose Lycopene Supplementation Increases Hepatic Cytochrome P4502E1 Protein and Inflammation in Alcohol-Fed Rats12. The Journal of Nutrition, 2008. 138(7): p. 1329-1335.
[25] Sahin, K., et al., Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food and Chemical Toxicology, 2010. 48(10): p. 2670-2674.
[26] Marcotorchino, J., et al., Lycopene attenuates LPS-induced TNF-α secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Molecular Nutrition and Food Research, 2012. 56(5): p. 725-732.
[27] Feng, D., W.H. Ling, and R.D. Duan, Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-κB in macrophages. Inflammation Research, 2010. 59(2): p. 115-121.
[28] Palozza, P., et al., Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. Journal of Nutritional Biochemistry, 2010. 21(1): p. 34-46.
[29] Buijsse, B., et al., Both alpha- and beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men. J Nutr, 2008. 138(2): p. 344-50.
[30] Pool-Zobel, B.L., et al., Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis, 1997. 18(9): p. 1847-50.
[31] Visioli, F., et al., Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr, 2003. 42(4): p. 201-6.
[32] Upritchard, J.E., W.H. Sutherland, and J.I. Mann, Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care, 2000. 23(6): p. 733-8.
[33] Watzl, B., et al., Prolonged tomato juice consumption has no effect on cell-mediated immunity of well-nourished elderly men and women. J Nutr, 2000. 130(7): p. 1719-23.
[34] Trivedi, P.P. and G.B. Jena, Mechanistic insight into beta-carotene-mediated protection against ulcerative colitis-associated local and systemic damage in mice. Eur J Nutr, 2015. 54(4): p. 639-52.
[35] Chen, H., et al., Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut, 2014. 63(5): p. 711-9.
[36] Li, X.Y., et al., Regulation of gut microbiota by vitamin C, vitamin E and β-carotene. Food Res Int, 2023. 169: p. 112749.
[37] Stevens, Y., et al., Effect of a carotenoid-producing Bacillus strain on intestinal barrier integrity and systemic delivery of carotenoids: A randomised trial in animals and humans. Journal of Functional Foods, 2021. 80: p. 104445.
[38] Wu, T., et al., Capsanthin extract prevents obesity, reduces serum TMAO levels and modulates the gut microbiota composition in high-fat-diet induced obese C57BL/6J mice. Food Research International, 2020. 128: p. 108774.
[39] Trivedi, P.P. and G.B. Jena, Mechanistic insight into beta-carotene-mediated protection against ulcerative colitis-associated local and systemic damage in mice. European Journal of Nutrition, 2015. 54(4): p. 639-652.
[40] Ushakumari, U.N. and R. Ramanujan, Isolation of astaxanthin from marine yeast and study of its pharmacological activity. International Current Pharmaceutical Journal, 2013. 2: p. 67-69.
[41] Naguib, Y.M., Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem, 2000. 48(4): p. 1150-4.
[42] Goto, S., et al., Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta, 2001. 1512(2): p. 251-8.
[43] Pereira, C.P.M., et al., Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). Int J Mol Med, 2021. 47(1): p. 37-48.
[44] Terazawa, S., et al., Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner. Exp Dermatol, 2012. 21 Suppl 1: p. 11-7.
[45] Sztretye, M., et al., Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging. Oxid Med Cell Longev, 2019. 2019: p. 3849692.
[46] Kim, S.H., J.W. Lim, and H. Kim, Astaxanthin Inhibits Mitochondrial Dysfunction and Interleukin-8 Expression in Helicobacter pylori-Infected Gastric Epithelial Cells. Nutrients, 2018. 10(9).
[47] Han, H., J.W. Lim, and H. Kim, Astaxanthin Inhibits Helicobacter pylori-induced Inflammatory and Oncogenic Responses in Gastric Mucosal Tissues of Mice. J Cancer Prev, 2020. 25(4): p. 244-251.
[48] Sakai, S., et al., Astaxanthin, a xanthophyll carotenoid, prevents development of dextran sulphate sodium-induced murine colitis. J Clin Biochem Nutr, 2019. 64(1): p. 66-72.
[49] Zhang, L., et al., Astaxanthin (ATX) enhances the intestinal mucosal functions in immunodeficient mice. Food Funct, 2020. 11(4): p. 3371-3381.
[50] Nagayama, T., et al., Effects of astaxanthin-enriched yeast on mucosal IgA induction in the jejunum and ileum of weanling mice. Anim Sci J, 2014. 85(4): p. 449-53.
[51] Ahn, Y.J. and H. Kim, Lutein as a Modulator of Oxidative Stress-Mediated Inflammatory Diseases. Antioxidants (Basel), 2021. 10(9).
[52] Nagira, M., et al., Ischemia/reperfusion injury in the monolayers of human intestinal epithelial cell line caco-2 and its recovery by antioxidants. Drug Metab Pharmacokinet, 2006. 21(3): p. 230-7.
[53] Sindhu, E.R., et al., Carotenoid lutein protects rats from paracetamol-, carbon tetrachloride- and ethanol-induced hepatic damage. J Pharm Pharmacol, 2010. 62(8): p. 1054-60.
[54] Vieira, M.M., et al., Carotenoids, retinol, and intestinal barrier function in children from northeastern Brazil. J Pediatr Gastroenterol Nutr, 2008. 47(5): p. 652-9.
[55] March, D.S., et al., Intestinal fatty acid-binding protein and gut permeability responses to exercise. Eur J Appl Physiol, 2017. 117(5): p. 931-941.
[56] Zhang, Y., et al., Lignin reinforced hydrogels with multi-functional sensing and moist-electric generating applications. International Journal of Biological Macromolecules, 2021. 193: p. 941-947.
[57] Prabhu Venkatesh, D., et al., In Vitro Evaluation of Antioxidant and Anti-inflammatory Potentials of Herbal Formulation Containing Marigold Flower (Calendula officinalis L.) Tea. Cureus, 2023. 15(8): p. e43308.
[58] Abidov, M., et al., The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes Metab, 2010. 12(1): p. 72-81.
[59] Kim, Y.-I., et al., GaN powders from ammonolysis: Preparation, structure, morphology, and optical properties. Solid State Sciences, 2011. 13(1): p. 216-223.
[60] Kijlstra, A., et al., Lutein: More than just a filter for blue light. Progress in Retinal and Eye Research, 2012. 31(4): p. 303-315.
[61] Shiratori, K., et al., Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Experimental Eye Research, 2005. 81(4): p. 422-428.
[62] Jin, X.H., et al., Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci, 2006. 47(6): p. 2562-8.
[63] Sasaki, M., et al., Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia, 2010. 53(5): p. 971-9.
[64] Milani, A., et al., Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol, 2017. 174(11): p. 1290-1324.
[65] Pérez-Gálvez, A., I. Viera, and M. Roca, Carotenoids and Chlorophylls as Antioxidants. Antioxidants (Basel), 2020. 9(6).
[66] Gammone, M.A., et al., Marine Carotenoids against Oxidative Stress: Effects on Human Health. Marine Drugs, 2015. 13(10): p. 6226-6246.
[67] Siems, W., et al., β-Carotene breakdown products may impair mitochondrial functions — potential side effects of high-dose β-carotene supplementation. The Journal of Nutritional Biochemistry, 2005. 16(7): p. 385-397.
[68] Gammone, M.A., G. Riccioni, and N. Orazio Marine Carotenoids against Oxidative Stress: Effects on Human Health. Marine Drugs, 2015. 13, 6226-6246
[69] Raposo, M.F., A.M. de Morais, and R.M. de Morais, Carotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic Diseases. Mar Drugs, 2015. 13(8): p. 5128-55.
[70] Kim, E.-A., et al. Antioxidant, Antiviral, and Anti-Inflammatory Activities of Lutein-Enriched Extract of Tetraselmis Species. Marine Drugs, 2023. 21.
[71] Murillo, A.G., S. Hu, and M.L. Fernandez, Zeaxanthin: Metabolism, Properties, and Antioxidant Protection of Eyes, Heart, Liver, and Skin. Antioxidants (Basel), 2019. 8(9).
[72] Crupi, P., et al. Overview of the Potential Beneficial Effects of Carotenoids on Consumer Health and Well-Being. Antioxidants, 2023. 12.
[73] Rashid, M., et al., Saffron as a Promising Therapy for Inflammatory Bowel Disease. Nutrients, 2024. 16(14).
[74] Wang, Y., et al., Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats. Experimental & Molecular Medicine, 2020. 52(12): p. 1959-1975.
[75] de Medeiros, P., et al., Modulation of Intestinal Immune and Barrier Functions by Vitamin A: Implications for Current Understanding of Malnutrition and Enteric Infections in Children. Nutrients, 2018. 10(9).
[76] Ruan, X., et al., Intramolecular heterostructured carbon nitride with heptazine-triazine for enhanced photocatalytic hydrogen evolution. Chemical Engineering Journal, 2022. 428: p. 132579.
[77] Jin, Y., et al., In vivo retinoid metabolic and visual cycle pathways assessment of carotenoid-rich refined red palm-pressed mesocarp olein. Journal of Functional Foods, 2024. 116: p. 106140.
[78] González-Prendes, R., et al., Modulatory Effect of Protein and Carotene Dietary Levels on Pig gut Microbiota. Sci Rep, 2019. 9(1): p. 14582.
[79] Djuric, Z., et al., Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations. Journal of the Academy of Nutrition and Dietetics, 2018. 118 4: p. 606-616.e3.
[80] Bohn, T., et al., Mechanistic aspects of carotenoid health benefits - where are we now? Nutr Res Rev, 2021. 34(2): p. 276-302.
[81] Pabst, O. and E. Slack, IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol, 2020. 13(1): p. 12-21.
[82] Mantis, N.J. and S.J. Forbes, Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest, 2010. 39(4-5): p. 383-406.
[83] Huus, K.E., et al., Commensal Bacteria Modulate Immunoglobulin A Binding in Response to Host Nutrition. Cell Host Microbe, 2020. 27(6): p. 909-921.e5.
[84] Stadtmueller, B.M., et al., The structure and dynamics of secretory component and its interactions with polymeric immunoglobulins. Elife, 2016. 5.
[85] Bennedsen, M., et al., Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol Lett, 1999. 70(3): p. 185-9.
[86] Baralic, I., et al., Effect of Astaxanthin Supplementation on Salivary IgA, Oxidative Stress, and Inflammation in Young Soccer Players. Evid Based Complement Alternat Med, 2015. 2015: p. 783761.
[87] Singh, D.P., et al., A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. Int J Obes (Lond), 2016. 40(3): p. 487-96.
[88] Wang, J., et al., Lycopene attenuates western-diet-induced cognitive deficits via improving glycolipid metabolism dysfunction and inflammatory responses in gut–liver–brain axis. International Journal of Obesity, 2019. 43(9): p. 1735-1746.
[89] Schreiber, O., et al., iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats. PLoS One, 2013. 8(8): p. e71843.
[90] Wang, J.L., et al., Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis. World J Gastroenterol, 2022. 28(43): p. 6109-6130.
[91] Djuric, Z., et al., Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations. Journal of the Academy of Nutrition and Dietetics, 2018. 118(4): p. 606-616.e3.
[92] Singh, N. and C.N. Bernstein, Environmental risk factors for inflammatory bowel disease. United European Gastroenterol J, 2022. 10(10): p. 1047-1053.
[93] Cai, Z., S. Wang, and J. Li, Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne), 2021. 8: p. 765474.
[94] Mehta, R.S., et al., Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. Nat Med, 2023. 29(3): p. 700-709.
[95] Simpson, J.B., et al., Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response. Gut Microbes, 2023. 15(1): p. 2203963.
[96] Prantera, C. and S. Marconi, Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity. Therap Adv Gastroenterol, 2013. 6(2): p. 137-56.
[97] Ali, S., et al., Glucocorticoids-Induced Neuropsychiatric Disorders in Patients With Inflammatory Bowel Disease: A Systematic Review. Cureus, 2022. 14(9): p. e28981.
[98] Papamichael, K., et al., Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases. Expert Rev Clin Immunol, 2019. 15(8): p. 837-848.
[99] Wu, N., et al., Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study. Clin Ther, 2014. 36(8): p. 1231-41, 1241.e1-3.
[100] Karthikeyan, A., et al., Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics, 2021. 13(4).